These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of cachexia and related components on pulmonary functions in patients with COPD. Görek Dilektaşli A, Ulubay G, Bayraktar N, Eminsoy I, Oner Eyüboğlu F. Tuberk Toraks; 2009; 57(3):298-305. PubMed ID: 19787469 [Abstract] [Full Text] [Related]
3. [Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease]. Peng M, Cai BQ, Ma Y, Zhu HJ, Sun Q, Song AL. Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):182-5. PubMed ID: 17572996 [Abstract] [Full Text] [Related]
4. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Yang YM, Sun TY, Liu XM. Chin Med J (Engl); 2006 Apr 20; 119(8):628-33. PubMed ID: 16635406 [Abstract] [Full Text] [Related]
5. Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients. Uzum AK, Aydin MM, Tutuncu Y, Omer B, Kiyan E, Alagol F. Eur J Intern Med; 2014 Apr 20; 25(4):364-9. PubMed ID: 23523152 [Abstract] [Full Text] [Related]
7. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease. Piehl-Aulin K, Jones I, Lindvall B, Magnuson A, Abdel-Halim SM. Respiration; 2009 Apr 20; 78(2):191-6. PubMed ID: 19270439 [Abstract] [Full Text] [Related]
9. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Karadag F, Kirdar S, Karul AB, Ceylan E. Eur J Intern Med; 2008 Mar 20; 19(2):104-8. PubMed ID: 18249305 [Abstract] [Full Text] [Related]
10. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Ju CR, Chen RC. Respir Med; 2012 Jan 20; 106(1):102-8. PubMed ID: 21840694 [Abstract] [Full Text] [Related]
12. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Kayacan O, Karnak D, Beder S, Güllü E, Tutkak H, Senler FC, Köksal D. Am J Clin Oncol; 2006 Aug 20; 29(4):328-35. PubMed ID: 16891858 [Abstract] [Full Text] [Related]
14. [Body mass index and serum and sputum TNF-alpha levels relation in asthma and COPD]. Başyiğit I, Yildiz F, Yildirim E, Boyaci H, Ilgazli A. Tuberk Toraks; 2004 Aug 20; 52(3):256-61. PubMed ID: 15351939 [Abstract] [Full Text] [Related]
16. Correlation between serum biomarkers and BODE index in patients with stable COPD. Liu SF, Chin CH, Wang CC, Lin MC. Respirology; 2009 Sep 20; 14(7):999-1004. PubMed ID: 19740260 [Abstract] [Full Text] [Related]
17. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M. Eur J Clin Invest; 2007 Nov 20; 37(11):897-904. PubMed ID: 17883420 [Abstract] [Full Text] [Related]
18. Circulating visfatin in chronic obstructive pulmonary disease. Liu X, Ji Y, Chen J, Li S, Luo F. Nutrition; 2009 Apr 20; 25(4):373-8. PubMed ID: 19056239 [Abstract] [Full Text] [Related]
19. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease]. Zhang Y, Yang SR, Cheng DY. Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar 20; 38(2):287-90. PubMed ID: 17441351 [Abstract] [Full Text] [Related]